NASDAQ : VANI

Vivani Medical, Inc. — Company profile

Healthcare · Biotechnology · United States

Last price 1.14 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 102.83M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Company profile

Vivani Medical, Inc., a clinical-stage biopharmaceutical company, engages in the development of miniaturized and subdermal drug implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates, alone or in collaboration with pharmaceutical company partners, to address causes of poor clinical outcomes in the treatment of chronic diseases. Its pipeline includes NPM-139 for chronic weight management in patients who are obese or overweight; NPM-133 a semaglutide implant for the treatment of patients with type 2 diabetes; NPM-115, an exenatide implant candidate for chronic weight management in patients who are obese or overweight; and OKV-119, an exenatide implant for the treatment of obesity and diabetes in companion animals, including cats and dogs. The company is headquartered in Alameda, California.

Details

NameVivani Medical, Inc.
SectorHealthcare
IndustryBiotechnology
Employees42
Founded1998
Ipo Date2014-11-19
CeoAdam Mendelsohn
CountryUnited States
ExchangeNASDAQ
Fiscal YearJanuary - December
Reporting CurrencyUSD
IsinUS92854B1098
Cusip92854B109
Cik0001266806
Sic3845
Stock TypeCommon Stock

Key executives

NameTitle
Dr. Adam Mendelsohn Ph.D.Co-Founder, Chief Executive Officer and Director
Anthony Edward Baldor M.B.A.Chief Financial Officer
Truc Le M.B.A.Chief Operations Officer
Dr. Lisa E. Porter M.D.Chief Medical Officer
Donald Dwyer M.B.A.Chief Business Officer and Corporate Secretary

Contact

Address1350 South Loop Road, Alameda, California 94502, United States
Phone415 506 8462
Websitehttps://www.vivani.com